VulnerabilityModified
CVE-2023-33364
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
HIGH 8.8EPSS 1.56%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.56%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.56% probability · 74th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-78
- Affected
- supremainc/biostar 2
- Source
- cve@mitre.org
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release Notes, Vendor Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release Notes, Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.